According to Zhitong Finance App News, Huiyu Pharmaceutical (688553.SH) disclosed its report for the third quarter of 2026. In the first three quarters, the company achieved operating income of 866 million yuan, an increase of 16.71%; net profit to mother was 103 million yuan, turning a year-on-year loss into a profit; deducted non-net profit of 134 million yuan, an increase of 68.59% over the previous year; and basic earnings per share were 0.17 yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.